Norden Group LLC Makes New Investment in Kenvue Inc. $KVUE

Norden Group LLC purchased a new stake in Kenvue Inc. (NYSE:KVUE) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 39,953 shares of the company’s stock, valued at approximately $689,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Salomon & Ludwin LLC acquired a new stake in Kenvue in the 3rd quarter valued at about $25,000. NBT Bank N A NY increased its position in Kenvue by 180.3% during the third quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock worth $25,000 after buying an additional 1,006 shares during the last quarter. Cornerstone Planning Group LLC increased its position in Kenvue by 705.2% during the third quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company’s stock worth $25,000 after buying an additional 1,361 shares during the last quarter. Golden State Wealth Management LLC raised its stake in Kenvue by 150.1% in the third quarter. Golden State Wealth Management LLC now owns 1,983 shares of the company’s stock valued at $32,000 after buying an additional 1,190 shares during the period. Finally, Trust Co. of Vermont raised its stake in Kenvue by 50.9% in the third quarter. Trust Co. of Vermont now owns 2,385 shares of the company’s stock valued at $39,000 after buying an additional 804 shares during the period. Institutional investors own 97.64% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently commented on the company. Citigroup lifted their target price on Kenvue from $18.00 to $20.00 and gave the stock a “neutral” rating in a research note on Wednesday, February 18th. Weiss Ratings restated a “hold (c-)” rating on shares of Kenvue in a research note on Friday, January 9th. Jefferies Financial Group downgraded Kenvue from a “buy” rating to a “hold” rating and cut their price target for the company from $23.00 to $18.00 in a report on Friday, January 30th. Barclays lifted their price objective on shares of Kenvue from $18.00 to $19.00 and gave the stock an “equal weight” rating in a research report on Friday, March 6th. Finally, Argus upgraded shares of Kenvue to a “hold” rating in a report on Friday, March 6th. Three research analysts have rated the stock with a Buy rating and thirteen have issued a Hold rating to the company. According to MarketBeat.com, Kenvue presently has a consensus rating of “Hold” and a consensus target price of $19.58.

Kenvue Price Performance

NYSE:KVUE opened at $17.52 on Friday. Kenvue Inc. has a 52 week low of $14.02 and a 52 week high of $25.17. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.68 and a current ratio of 0.96. The firm’s 50-day simple moving average is $18.01 and its 200 day simple moving average is $17.13. The firm has a market cap of $33.57 billion, a price-to-earnings ratio of 22.75, a P/E/G ratio of 3.98 and a beta of 0.51.

Kenvue (NYSE:KVUE) last posted its quarterly earnings data on Tuesday, February 17th. The company reported $0.27 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.22 by $0.05. Kenvue had a net margin of 9.72% and a return on equity of 19.72%. The firm had revenue of $3.78 billion during the quarter, compared to the consensus estimate of $3.68 billion. During the same quarter in the previous year, the firm posted $0.26 EPS. The business’s revenue for the quarter was up 3.2% compared to the same quarter last year. As a group, sell-side analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, February 25th. Investors of record on Wednesday, February 11th were paid a $0.2075 dividend. This represents a $0.83 annualized dividend and a dividend yield of 4.7%. The ex-dividend date was Wednesday, February 11th. Kenvue’s payout ratio is 107.79%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.